📣 VC round data is live. Check it out!
- Public Comps
- enVVeno Medical
enVVeno Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for enVVeno Medical and similar public comparables like Carmat, Redsense Medical, AMA Corp, Pheton Holdings and more.
enVVeno Medical Overview
About enVVeno Medical
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
Founded
1999
HQ

Employees
37
Website
Financials (FY)
Market Cap
$7M
Valuation Multiples
Start free trialenVVeno Medical Financials
enVVeno Medical reported last fiscal year revenue of - and negative EBITDA of ($20M).
In the same fiscal year, enVVeno Medical generated ($20M) in EBITDA losses and had net loss of ($19M).
Revenue (LTM)
enVVeno Medical P&L
In the most recent fiscal year, enVVeno Medical reported revenue of - and EBITDA of ($20M).
enVVeno Medical is unprofitable as of last fiscal year, with EBITDA margin of - and net margin of -.
Financial data powered by Morningstar, Inc.
enVVeno Medical Stock Performance
enVVeno Medical has current market cap of $7M.
Market Cap Evolution
enVVeno Medical's stock price is $10.67.
enVVeno Medical share price decreased by 3.9% in the last 30 days, and by 92.4% in the last year.
enVVeno Medical has an EPS (earnings per share) of $-29.16.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| $7M | -3.9% | -3.9% | 5.4% | -92.4% | $-29.16 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialenVVeno Medical Valuation Multiples
enVVeno Medical trades at 0.8x EV/EBITDA.
EV / Revenue (LTM)
enVVeno Medical Financial Valuation Multiples
As of June 3, 2026, enVVeno Medical has market cap of $7M.
enVVeno Medical has a P/E ratio of (0.4x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified enVVeno Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


enVVeno Medical Margins & Growth Rates
enVVeno Medical Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
enVVeno Medical Operational KPIs
enVVeno Medical's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.6M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
enVVeno Medical Competitors
enVVeno Medical competitors include Carmat, Redsense Medical, AMA Corp, Pheton Holdings, Qlife Holding, Bio-Gate, Lucyd, ScandiDos, Predict and Inventionmed.
Most enVVeno Medical public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| - | - | - | - | |||
| 2.2x | - | (8.3x) | - | |||
| 3.3x | - | (1.3x) | - | |||
| - | - | - | - | |||
| 199.0x | - | (3.5x) | - | |||
| 0.9x | 0.8x | (4.8x) | (11.8x) | |||
| 0.3x | 0.2x | (0.1x) | (0.1x) | |||
| 0.8x | - | 20.4x | - | |||
This data is available for Pro users. Sign up to see all enVVeno Medical competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout enVVeno Medical
| When was enVVeno Medical founded? | enVVeno Medical was founded in 1999. |
| Where is enVVeno Medical headquartered? | enVVeno Medical is headquartered in United States. |
| How many employees does enVVeno Medical have? | As of today, enVVeno Medical has over 37 employees. |
| Who is the CEO of enVVeno Medical? | enVVeno Medical's CEO is Robert A. Berman. |
| Is enVVeno Medical publicly listed? | Yes, enVVeno Medical is a public company listed on Nasdaq. |
| What is the stock symbol of enVVeno Medical? | enVVeno Medical trades under NVNO ticker. |
| When did enVVeno Medical go public? | enVVeno Medical went public in 2018. |
| Who are competitors of enVVeno Medical? | enVVeno Medical main competitors include Carmat, Redsense Medical, AMA Corp, Pheton Holdings, Qlife Holding, Bio-Gate, Lucyd, ScandiDos, Predict, Inventionmed. |
| What is the current market cap of enVVeno Medical? | enVVeno Medical's current market cap is $7M. |
| Is enVVeno Medical profitable? | No, enVVeno Medical is not profitable. |
| How many companies enVVeno Medical has acquired to date? | enVVeno Medical hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies enVVeno Medical has invested to date? | enVVeno Medical hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to enVVeno Medical
Lists including enVVeno Medical
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.